|
|
Blood, 1 July 2008, Vol. 112, No. 1, pp. 196-207.
Prepublished online as a Blood First Edition Paper on February 27, 2008; DOI 10.1182/blood-2008-01-132134.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
Ya-Wei Qiang1,
Yu Chen1,
Owen Stephens1,
Nathan Brown1,
Bangzheng Chen1,
Joshua Epstein1,
Bart Barlogie1, and
John D. Shaughnessy, Jr1
1 Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock
Multiple myeloma (MM) is characterized by osteolytic bone lesions (OBL) that arise as a consequence of osteoblast inactivation and osteoclast activation adjacent to tumor foci within bone. Wnt signaling in osteoblasts regulates osteoclastogenesis through the differential activation and inactivation of Receptor Activator of Nuclear factor Kappa B Ligand (RANKL) and osteoprotegerin (OPG), positive and negative regulators of osteoclast differentiation, respectively. We demonstrate here that MM cell–derived DKK1, a soluble inhibitor of canonical Wnt signaling, disrupted Wnt3a-regulated OPG and RANKL expression in osteoblasts. Confirmed in multiple independent assays, we show that pretreatment with rDKK1 completely abolished Wnt3a-induced OPG mRNA and protein production by mouse and human osteoblasts. In addition, we show that Wnt3a-induced OPG expression was diminished in osteoblasts cocultured with a DKK1-expressing MM cell line or primary MM cells. Finally, we show that bone marrow sera from 21 MM patients significantly suppressed Wnt3a-induced OPG expression and enhanced RANKL expression in osteoblasts in a DKK1-dependent manner. These results suggest that DKK1 may play a key role in the development of MM-associated OBL by directly interrupting Wnt-regulated differentiation of osteoblasts and indirectly increasing osteoclastogenesis via a DKK1-mediated increase in RANKL-to-OPG ratios.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
MM-induced osteolysis: partners in crime
- Carl Gregory
Blood 2008 112: 3-4.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
E. Voskaridou, D. Christoulas, C. Xirakia, K. Varvagiannis, G. Boutsikas, A. Bilalis, E. Kastritis, A. Papatheodorou, and E. Terpos
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
Haematologica,
May 1, 2009;
94(5):
725 - 728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Sezer
Myeloma Bone Disease: Recent Advances in Biology, Diagnosis, and Treatment
Oncologist,
March 1, 2009;
14(3):
276 - 283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Pinzone, B. M. Hall, N. K. Thudi, M. Vonau, Y.-W. Qiang, T. J. Rosol, and J. D. Shaughnessy Jr
The role of Dickkopf-1 in bone development, homeostasis, and disease
Blood,
January 15, 2009;
113(3):
517 - 525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-W. Qiang, J. D. Shaughnessy Jr, and S. Yaccoby
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
Blood,
July 15, 2008;
112(2):
374 - 382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Li, A. Pennisi, and S. Yaccoby
Role of decorin in the antimyeloma effects of osteoblasts
Blood,
July 1, 2008;
112(1):
159 - 168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
